BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33017573)

  • 1. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway.
    Zhang G; Jin C; Zhu Y; Fu F; Wang G; Li S
    Life Sci; 2020 Dec; 263():118485. PubMed ID: 33017573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphene enhances radiosensitivity of hepatocellular carcinoma through suppression of the NF-κB pathway.
    Ren K; Li Z; Li Y; Zhang W; Han X
    J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28346727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Punicalagin suppresses osteosarcoma growth and metastasis by regulating NF-κB signaling.
    Wang XZ; Zhang SF; Yang ZH; Ye ZW; Liu J
    J Biol Regul Homeost Agents; 2020; 34(5):1699-1708. PubMed ID: 33148374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms.
    Jin W; Gu C; Zhou L; Yang X; Gui M; Zhang J; Chen J; Dong X; Yuan Q; Shan L
    Oncol Rep; 2020 Dec; 44(6):2621-2633. PubMed ID: 33125106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Punicalagin inhibited proliferation, invasion and angiogenesis of osteosarcoma through suppression of NF‑κB signaling.
    Huang T; Zhang X; Wang H
    Mol Med Rep; 2020 Sep; 22(3):2386-2394. PubMed ID: 32705250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
    Liu YK; Jia YJ; Liu SH; Ma J
    Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amentoflavone Inhibits Metastatic Potential Through Suppression of ERK/NF-κB Activation in Osteosarcoma U2OS Cells.
    Pan PJ; Tsai JJ; Liu YC
    Anticancer Res; 2017 Sep; 37(9):4911-4918. PubMed ID: 28870912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
    Wang Y; Fu Q; Zhao W
    Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation.
    Ni S; Miao K; Zhou X; Xu N; Li C; Zhu R; Sun R; Wang Y
    Arthritis Res Ther; 2015 Apr; 17(1):91. PubMed ID: 25888873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway.
    Liao D; Zhong L; Duan T; Zhang RH; Wang X; Wang G; Hu K; Lv X; Kang T
    Clin Cancer Res; 2015 Dec; 21(23):5349-59. PubMed ID: 26202947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
    J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1.
    Yang M; Teng W; Qu Y; Wang H; Yuan Q
    Breast Cancer Res Treat; 2016 Jul; 158(2):277-86. PubMed ID: 27377973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
    Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
    Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
    Peng L; Liu A; Shen Y; Xu HZ; Yang SZ; Ying XZ; Liao W; Liu HX; Lin ZQ; Chen QY; Cheng SW; Shen WD
    Oncol Rep; 2013 Feb; 29(2):571-8. PubMed ID: 23232982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-κB axis.
    Cao H; Han X; Jia Y; Zhang B
    Aging (Albany NY); 2021 Apr; 13(8):11455-11469. PubMed ID: 33839699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
    Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q
    Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
    Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
    Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
    Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
    Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cells.
    Chen X; Gu N; Xue C; Li BR
    Mol Med Rep; 2018 Feb; 17(2):3239-3245. PubMed ID: 29257319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway.
    Zhao Z; Wu MS; Zou C; Tang Q; Lu J; Liu D; Wu Y; Yin J; Xie X; Shen J; Kang T; Wang J
    Cancer Lett; 2014 Jan; 342(1):150-8. PubMed ID: 24012639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.